PHARMADAX INC FDA Approval ANDA 212106

ANDA 212106

PHARMADAX INC

FDA Drug Application

Application #212106

Application Sponsors

ANDA 212106PHARMADAX INC

Marketing Status

Prescription001
Prescription002

Application Products

001TABLET;ORAL0.5MG0ENTECAVIRENTECAVIR
002TABLET;ORAL1MG0ENTECAVIRENTECAVIR

FDA Submissions

UNKNOWN; ORIG1AP2020-08-10STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAB
002PrescriptionAB

CDER Filings

PHARMADAX INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 212106
            [companyName] => PHARMADAX INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"ENTECAVIR","activeIngredients":"ENTECAVIR","strength":"0.5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"ENTECAVIR","activeIngredients":"ENTECAVIR","strength":"1MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"08\/10\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-08-10
        )

)

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.